Jennie Medin

1.0k total citations
39 papers, 711 citations indexed

About

Jennie Medin is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Jennie Medin has authored 39 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Jennie Medin's work include Multiple Sclerosis Research Studies (17 papers), Sphingolipid Metabolism and Signaling (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Jennie Medin is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Sphingolipid Metabolism and Signaling (6 papers) and Peripheral Neuropathies and Disorders (4 papers). Jennie Medin collaborates with scholars based in Switzerland, United States and Sweden. Jennie Medin's co-authors include Kerstin Ekberg, Anders Nordlund, Ángel Lanas, Ping Wu, Edward J. Mills, Tjalf Ziemssen, Hari Shankar Sharma, Aoife Callan, Catherine Mitchell and Jonathan R. Korn and has published in prestigious journals such as Gastroenterology, PLoS ONE and Neurology.

In The Last Decade

Jennie Medin

36 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennie Medin Switzerland	13	239	148	136	114	103	39	711
Sebastian Fetscher Germany	15	152 0.6×	97 0.7×	67 0.5×	67 0.6×	76 0.7×	45	1.8k
László Kardos Hungary	16	80 0.3×	230 1.6×	85 0.6×	41 0.4×	153 1.5×	53	834
Yi-Ju Chiang United States	23	170 0.7×	144 1.0×	144 1.1×	8 0.1×	55 0.5×	47	1.6k
Krista Payne United States	14	86 0.4×	84 0.6×	103 0.8×	22 0.2×	53 0.5×	21	893
Akiko Kada Japan	16	87 0.4×	123 0.8×	291 2.1×	30 0.3×	55 0.5×	86	866
Marieke M. ter Wee Netherlands	17	238 1.0×	55 0.4×	47 0.3×	16 0.1×	107 1.0×	68	1.1k
JE Manson United States	10	150 0.6×	234 1.6×	326 2.4×	8 0.1×	71 0.7×	16	1.5k
Helena Harder United Kingdom	17	135 0.6×	46 0.3×	26 0.2×	42 0.4×	67 0.7×	26	899
Daniel Wachtlin Germany	18	76 0.3×	67 0.5×	61 0.4×	19 0.2×	27 0.3×	33	1.0k
Ahmed Kotb Canada	9	132 0.6×	73 0.5×	115 0.8×	8 0.1×	60 0.6×	24	753

Countries citing papers authored by Jennie Medin

Since Specialization

Citations

This map shows the geographic impact of Jennie Medin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennie Medin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennie Medin more than expected).

Fields of papers citing papers by Jennie Medin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennie Medin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennie Medin. The network helps show where Jennie Medin may publish in the future.

Co-authorship network of co-authors of Jennie Medin

This figure shows the co-authorship network connecting the top 25 collaborators of Jennie Medin. A scholar is included among the top collaborators of Jennie Medin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennie Medin. Jennie Medin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müllerová, Hana, Jennie Medin, Matthew Arnold, et al.. (2023). Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic. BMJ Open. 13(1). e063645–e063645.

Laffan, Michael, et al.. (2022). Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations. Vaccine. 40(38). 5585–5593. 6 indexed citations

Nicolucci, Antonio, Hungta Chen, Javier Cid‐Ruzafa, et al.. (2021). Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study. Diabetes Research and Clinical Practice. 180. 108974–108974. 3 indexed citations

James, Glen, Anna Niklasson, Katarina Hedman, et al.. (2020). Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study. Journal of Medical Internet Research. 22(7). e18548–e18548. 12 indexed citations

Medin, Jennie, et al.. (2018). Estimated prevalence of secondary progressive multiple sclerosis in the USA and Europe: results from a systematic literature search (P2.380). Neurology. 90(15_supplement). 11 indexed citations

Zivadinov, Robert, Jennie Medin, Nasreen Khan, et al.. (2018). Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27. 65–73. 5 indexed citations

Dwyer, Michael G., Jesper Hagemeier, Niels Bergsland, et al.. (2018). Establishing pathological cut-offs for lateral ventricular volume expansion rates. NeuroImage Clinical. 18. 494–501. 25 indexed citations

Jood, Katarina, et al.. (2017). The psychosocial work environment is associated with risk of stroke at working age. Scandinavian Journal of Work Environment & Health. 43(4). 367–374. 24 indexed citations

Zivadinov, Robert, Niels Bergsland, Jonathan R. Korn, et al.. (2017). Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. American Journal of Neuroradiology. 39(2). 289–295. 24 indexed citations

10.

Meier, Daniela Piani, et al.. (2017). Multiple Sclerosis Care Optimization Tool (MS-COT): A Clinical application prototype to predict future disease activity (P1.368). Neurology. 88(16_supplement). 1 indexed citations

11.

Korn, Jonathan R., Jennie Medin, Juanzhi Fang, & Norman Putzki. (2017). Persistence with multiple sclerosis disease-modifying therapies is highest when switching to fingolimod compared with other oral and injectable therapies: a retrospective US claims database analysis (P2.397). Neurology. 88(16_supplement). 1 indexed citations

12.

Alsop, Jonathan, Jennie Medin, Christian Cornelissen, Stefan Viktor Vormfelde, & Tjalf Ziemssen. (2017). Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL. PLoS ONE. 12(5). e0173353–e0173353. 15 indexed citations

13.

Ziemssen, Tjalf, Michael Lang, Björn Tackenberg, et al.. (2017). Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA. Neurotherapeutics. 15(1). 190–199. 12 indexed citations

14.

Ziemssen, Tjalf, et al.. (2017). Multiple sclerosis in the real world: A systematic review of fingolimod as a case study. Autoimmunity Reviews. 16(4). 355–376. 47 indexed citations

15.

Medin, Jennie, et al.. (2016). Predicting Disease Activity for Patients with Relapsing Remitting Multiple Sclerosis Using Electronic Medical Records (P1.395). Neurology. 86(16_supplement). 1 indexed citations

16.

Zivadinov, Robert, Nasreen Khan, Jennie Medin, et al.. (2016). An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study. Journal of Neuroimaging. 27(3). 339–347. 12 indexed citations

17.

Bergvall, Niklas, et al.. (2015). Confirmed Disability Improvement In Patients With Active Multiple Sclerosis Treated With Fingolimod Versus Brace: A Matched Comparison of Treatments From The Pangaea And Pearl Registry Studies. Value in Health. 18(7). A750–A750. 6 indexed citations

18.

Medin, Jennie, Rob Arbuckle, Linda Abetz, et al.. (2014). Development and Validation of the AFSymp™: An Atrial Fibrillation-Specific Measure of Patient-Reported Symptoms. Patient. 7(3). 319–327. 8 indexed citations

19.

Medin, Jennie, Anders Nordlund, & Kerstin Ekberg. (2007). Sick leave, disability pension and health-care-seeking behaviour prior to stroke, among people aged 30–65: A case–control study. Brain Injury. 21(5). 457–463. 9 indexed citations

20.

Medin, Jennie, Anders Nordlund, & Kerstin Ekberg. (2004). Increasing Stroke Incidence in Sweden Between 1989 and 2000 Among Persons Aged 30 to 65 Years: Evidence From the Swedish Hospital Discharge Register. Stroke. 35(5). 1047–1051. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact